If you are wondering whether Bristol-Myers Squibb is priced attractively right now, you are not alone. This article walks ...

Bristol-Myers Squibb (BMY) has been drawing attention after its shares closed at $56.72, leaving investors weighing how ...

Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

A federal appeals court on Wednesday blocked a Trump administration plan to require hospitals serving low-income Americans to ...

Fintel reports that on January 7, 2026, UBS upgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Neutral to Buy.

The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...

The Dow" is short for the Dow Jones Industrial Average. It's often used as a proxy for the entire U.S. stock market.

New data show that psychiatric advanced practice practitioners provide guideline-concordant schizophrenia care that is ...

The launch of USA-based Poplar Therapeutics has been announced, alongside a $50 million Series A financing led by SR One, ...

AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board  Seasoned executive with extensive ...

A US appeals court blocked the Trump administration’s drug rebate plan, ruling safety-net hospitals cannot be forced to pay ...

A report in the Wall Street Journal, citing people familiar with the matter, suggested an announcement of a transaction could ...